[{"Assets_0_Q2_USD":655188000.0,"CommonStockSharesOutstanding_0_Q2_shares":161917424.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-76637000.0,"NetIncomeLoss_1_Q2_USD":-38766000.0,"NetIncomeLoss_2_Q2_USD":-99475000.0,"StockholdersEquity_0_Q2_USD":279223000.0,"Ticker":"PGEN","CIK":"1356090","name":"INTREXON CORP","OfficialName":"Precigen Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337298902.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190809"}]